MD2491F1 - Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment - Google Patents

Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment Download PDF

Info

Publication number
MD2491F1
MD2491F1 MD20040035A MD20040035A MD2491F1 MD 2491 F1 MD2491 F1 MD 2491F1 MD 20040035 A MD20040035 A MD 20040035A MD 20040035 A MD20040035 A MD 20040035A MD 2491 F1 MD2491 F1 MD 2491F1
Authority
MD
Moldova
Prior art keywords
algodysmenorrhea
treatment
isoturone
bromide
ethyl isothiouronium
Prior art date
Application number
MD20040035A
Other languages
Romanian (ro)
Other versions
MD2491G2 (en
Inventor
Victor GHICAVII
Mihail Todiras
Valentin FRIPTU
Ecaterina Stratu
Corina Cardaniuc
Michael Bader
Original Assignee
Victor GHICAVII
Mihail Todiras
Valentin FRIPTU
Ecaterina Stratu
Corina Cardaniuc
Michael Bader
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victor GHICAVII, Mihail Todiras, Valentin FRIPTU, Ecaterina Stratu, Corina Cardaniuc, Michael Bader filed Critical Victor GHICAVII
Priority to MDA20040035A priority Critical patent/MD2491G2/en
Publication of MD2491F1 publication Critical patent/MD2491F1/en
Publication of MD2491G2 publication Critical patent/MD2491G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to gynecology, and may be used for treatment of primary and secondary algodysmenorrhea to patients with menstrual cycle disorders. Summary of the invention consists in the use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment. The result consists in that when locally using said medicinal preparation in 95...100% cases there is attained disappearance of the pain syndrome. Claims: 1
MDA20040035A 2004-02-10 2004-02-10 Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment MD2491G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20040035A MD2491G2 (en) 2004-02-10 2004-02-10 Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20040035A MD2491G2 (en) 2004-02-10 2004-02-10 Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Publications (2)

Publication Number Publication Date
MD2491F1 true MD2491F1 (en) 2004-07-31
MD2491G2 MD2491G2 (en) 2005-01-31

Family

ID=32768683

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20040035A MD2491G2 (en) 2004-02-10 2004-02-10 Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Country Status (1)

Country Link
MD (1) MD2491G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2850G2 (en) * 2005-02-18 2006-07-31 Валентин ФРИПТУ Method of inducing the medicamental abortion

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3644G2 (en) * 2008-03-17 2009-02-28 Рафаэль Баркан Preparation for algodismenorrhea treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (en) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ "Isoturon" means with antihypotensive activity
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies
MD2323G2 (en) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2850G2 (en) * 2005-02-18 2006-07-31 Валентин ФРИПТУ Method of inducing the medicamental abortion

Also Published As

Publication number Publication date
MD2491G2 (en) 2005-01-31

Similar Documents

Publication Publication Date Title
YU30004A (en) Use of flibanserin in the treatment of sexual disorders
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
NZ591362A (en) Multiple-variable dose regimen for treating tnfa-related disorders
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
SE9702860D0 (en) New use
WO2002069945A3 (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
GB0020504D0 (en) Therapeutic method
WO2001076601A3 (en) Pharmaceutical compositions comprising salmeterol and ipratropium
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
EP1393738A4 (en) ANTIDIABETIC TREATMENT
SE9902597D0 (en) New use
CA2396209A1 (en) The use of mirtazapine for the treatment of sleep disorders
MD2491F1 (en) Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment
UA83018C2 (en) Combination comprising roflumilast and formoterol for treatment of respiratory tract disorders
SE0102887D0 (en) New formulation
HUP0004461A2 (en) Use of apolipoprotein b secretion/microsomal triglyceride transfer protein inhibitor for producing pharmaceutical composition and these pharmaceutical compositions
BR0313305A (en) Analgesic agent for newborn or fetal individuals
MD2323F1 (en) Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
Ochiai et al. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate
PT1567140E (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
MD3644G2 (en) Preparation for algodismenorrhea treatment
WO2002028430A3 (en) Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees